Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inari Medical Inc (NARI)

Inari Medical Inc (NARI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,017,943
  • Shares Outstanding, K 58,544
  • Annual Sales, $ 493,630 K
  • Annual Income, $ -1,640 K
  • EBIT $ -55 M
  • EBITDA $ -58 M
  • 60-Month Beta 0.97
  • Price/Sales 6.18
  • Price/Cash Flow 591.10
  • Price/Book 7.02

Options Overview Details

View History
  • Implied Volatility 60.41% ( +2.32%)
  • Historical Volatility 55.56%
  • IV Percentile 68%
  • IV Rank 41.18%
  • IV High 99.55% on 10/28/24
  • IV Low 33.01% on 09/09/24
  • Put/Call Vol Ratio 0.68
  • Today's Volume 37
  • Volume Avg (30-Day) 148
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 2,994
  • Open Int (30-Day) 4,188

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 9
  • High Estimate 0.04
  • Low Estimate -0.28
  • Prior Year 0.05
  • Growth Rate Est. (year over year) -160.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.96 +8.84%
on 11/20/24
53.67 -2.74%
on 11/12/24
+3.27 (+6.68%)
since 11/04/24
3-Month
39.76 +31.29%
on 10/01/24
53.67 -2.74%
on 11/12/24
+9.12 (+21.17%)
since 09/04/24
52-Week
36.73 +42.12%
on 04/22/24
67.13 -22.24%
on 12/14/23
-10.57 (-16.84%)
since 12/04/23

Most Recent Stories

More News
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 14.83 (+2.70%)
ARAY : 2.03 (-3.33%)
MASI : 171.71 (-1.42%)
NARI : 52.20 (+1.26%)
Inari Medical Announces Joint Venture with 6 Dimensions Capital and VFLO Medical to Expand Access in Greater China

Inari Medical announces a joint venture with 6 Dimensions Capital and VFLO Medical to enhance healthcare access in Greater China.Quiver AI SummaryInari Medical, Inc. has announced a joint venture with...

NARI : 52.20 (+1.26%)
Inari Medical Receives National Reimbursement Approval for ClotTriever Thrombectomy System in Japan

Inari Medical received Japanese reimbursement approval for ClotTriever, enhancing DVT treatment options through a new functional category.Quiver AI SummaryInari Medical, Inc. announced that it received...

NARI : 52.20 (+1.26%)
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

NARI : 52.20 (+1.26%)
Inari Medical Announces Joint Venture in Greater China

NARI : 52.20 (+1.26%)
Insider Sale: President and CEO of $NARI (NARI) Sells 3,000 Shares

Andrew Hykes, the President and CEO of $NARI ($NARI), sold 3,000 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their...

NARI : 52.20 (+1.26%)
Insider Sale: Director at $NARI (NARI) Sells 9,750 Shares

William Hoffman, a director at $NARI ($NARI), sold 9,750 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of their shares....

NARI : 52.20 (+1.26%)
Inari Medical to Participate in the Jefferies London Healthcare Conference

NARI : 52.20 (+1.26%)
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

NARI : 52.20 (+1.26%)
Inari Medical Reports Third Quarter 2024 Financial Results

NARI : 52.20 (+1.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its...

See More

Key Turning Points

3rd Resistance Point 54.32
2nd Resistance Point 53.33
1st Resistance Point 52.76
Last Price 52.20
1st Support Level 51.20
2nd Support Level 50.21
3rd Support Level 49.64

See More

52-Week High 67.13
Fibonacci 61.8% 55.52
Last Price 52.20
Fibonacci 50% 51.93
Fibonacci 38.2% 48.34
52-Week Low 36.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar